Literature DB >> 30559251

The connexin 30 A88V mutant reduces cochlear gap junction expression and confers long-term protection against hearing loss.

John J Kelly1, Julia M Abitbol1, Stephanie Hulme1, Eric R Press1, Dale W Laird1, Brian L Allman2.   

Abstract

Mutations in the genes that encode the gap junction proteins connexin 26 (Cx26, encoded by GJB2) and Cx30 (GJB6) are the leading cause of hereditary hearing loss. That said, the Cx30 p.Ala88Val (A88V) mutant causes Clouston syndrome, but not hearing loss. Here, we report that the Cx30-A88V mutant, despite being toxic to inner ear-derived HEI-OC1 cells, conferred remarkable long-term protection against age-related high frequency hearing loss in Cx30A88V/A88V mice. During early development, there were no overt structural differences in the cochlea between genotypes, including a normal complement of hair cells; however, the supporting cell Cx30 gap junction plaques in mutant mice were reduced in size. In adulthood, Cx30A88V/A88V mutant mice had a reduction of cochlear Cx30 mRNA and protein, yet a full complement of hair cells. Conversely, the age-related high frequency hearing loss in Cx30+/+ and Cx30+/A88V mice was due to extensive loss of outer hair cells. Our data suggest that the Cx30-A88V mutant confers long-term hearing protection and prevention of hair cell death, possibly via a feedback mechanism that leads to the reduction of total Cx30 gap junction expression in the cochlea.
© 2019. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Aging; Clouston syndrome; Connexin; Cx30; GJB6; Gap junction; Hearing; Mouse

Mesh:

Substances:

Year:  2019        PMID: 30559251     DOI: 10.1242/jcs.224097

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  6 in total

1.  A potent antagonist antibody targeting connexin hemichannels alleviates Clouston syndrome symptoms in mutant mice.

Authors:  Yuanyuan Kuang; Veronica Zorzi; Damiano Buratto; Gaia Ziraldo; Flavia Mazzarda; Chiara Peres; Chiara Nardin; Anna Maria Salvatore; Francesco Chiani; Ferdinando Scavizzi; Marcello Raspa; Min Qiang; Youjun Chu; Xiaojie Shi; Yu Li; Lili Liu; Yaru Shi; Francesco Zonta; Guang Yang; Richard A Lerner; Fabio Mammano
Journal:  EBioMedicine       Date:  2020-06-15       Impact factor: 8.143

2.  Investigating the characteristics of genes and variants associated with self-reported hearing difficulty in older adults in the UK Biobank.

Authors:  Morag A Lewis; Bradley A Schulte; Judy R Dubno; Karen P Steel
Journal:  BMC Biol       Date:  2022-06-27       Impact factor: 7.364

3.  Gap Junction-Mediated Intercellular Communication of cAMP Prevents CDDP-Induced Ototoxicity via cAMP/PKA/CREB Pathway.

Authors:  Yeon Ju Kim; Jin-Sol Lee; Hantai Kim; Jeong Hun Jang; Yun-Hoon Choung
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

4.  Cx26 keratitis ichthyosis deafness syndrome mutations trigger alternative splicing of Cx26 to prevent expression and cause toxicity in vitro.

Authors:  Jonathan Cook; Elizabeth de Wolf; Nicholas Dale
Journal:  R Soc Open Sci       Date:  2019-08-07       Impact factor: 2.963

5.  Mutant Cx30-A88V mice exhibit hydrocephaly and sex-dependent behavioral abnormalities, implicating a functional role for Cx30 in the brain.

Authors:  Nicole M Novielli-Kuntz; Eric R Press; Kevin Barr; Marco A M Prado; Dale W Laird
Journal:  Dis Model Mech       Date:  2021-01-26       Impact factor: 5.758

6.  GJB2 Mutations Linked to Hearing Loss Exhibit Differential Trafficking and Functional Defects as Revealed in Cochlear-Relevant Cells.

Authors:  Rianne Beach; Julia M Abitbol; Brian L Allman; Jessica L Esseltine; Qing Shao; Dale W Laird
Journal:  Front Cell Dev Biol       Date:  2020-04-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.